MedTrace Logo

Transfusion Effects in Myelodysplastic Patients: Limiting Exposure

NCT00202371 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2023-11-24

No results posted yet for this study

Summary

The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger: 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger: 9.6 gr/dl) on physical fatigue.

Conditions

Interventions

PROCEDURE

Red Blood Cell transfusion

Sponsors & Collaborators

  • Ministry of Health, Welfare and Sports, The Netherlands

    collaborator UNKNOWN

  • Sanquin Research & Blood Bank Divisions

    lead OTHER

Principal Investigators

  • Dick J van Rhenen, MD, PhD · Sanquin Blood Bank South West Region

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-07-31
Completion
2005-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00202371 on ClinicalTrials.gov